BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B
BiohacksAI/Targets/CYP17A1/Compounds

Compounds That Target CYP17A1

cytochrome P450 family 17 subfamily A member 1 · 10 compounds in BiohacksAI corpus

CYP17A1 (cytochrome P450 family 17 subfamily A member 1) is a cytochrome P450 enzyme involved in the metabolism of drugs, hormones, and dietary compounds. CYP enzymes are critical determinants of pharmacokinetics and drug-herb interactions. The 10 compounds listed here have documented interactions with CYP17A1 based on BindingDB inhibition and binding assay data, making this resource valuable for assessing compound safety and interaction profiles.

View CYP17A1 target page →UniProt: P05093 ↗
Most Studied Compounds for CYP17A1
1
Testosterone Propionate
300+
studies
2
Econazole
299+
studies
3
Miconazole
298+
studies
4
Abiraterone Acetate
296+
studies
All 10 Compounds — Ranked by Evidence
1
Bifonazole
3.71
confidence
2
Abiraterone
3.66
confidence
3
Galeterone
2.64
confidence
4
Tioconazole
2.56
confidence
5
Azalanstat
2.20
confidence
6
Abiraterone Acetate
296+
studies
1.10
confidence
7
Clotrimazoleheterocyclic
0.69
confidence
8
Econazole
299+
studies
0.69
confidence
9
Miconazole
298+
studies
0.69
confidence
10
Testosterone Propionate
300+
studies
0.69
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for CYP17A1 (cytochrome P450 family 17 subfamily A member 1). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: CYP17A1 target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.